Ethiopia Completes Marburg Vaccine Trial, Analyzes Results: Technical Lead The trial involved 631 at-risk individuals exposed to the virus, with 518 successfully completing the process, Dr. Mezgebu, the technical lead of the trial at the Armauer Hansen Research Institute, told Sputnik Africa on the sidelines of the 28th Health Sector Annual Review Meeting in Hosanna City. Key facts about the trial, according to the speaker: 🟠Innovative Approach: Conducted during an actual outbreak, the trial uniquely integrated research with routine medical care, yielding encouraging results. 🟠Next Steps: Researchers are now analyzing the collected samples before officially publishing the findings through various channels. 🟠Strategic Impact: The initiative marks a crucial step in strengthening Ethiopia's national capacity to research and respond to future public health emergencies. Subscribe to @sputnik_africa 🔸 Sputnik Africa | X 🔸